Rapid Results

Coronavirus (COVID-19)/Influenza A/B (Flu A/B)/Respiratory Syncytial Virus (RSV)/Adenovirus (Adeno) Antigen Combo Rapid Test

Simultaneous detection of COVID-19, Influenza A/B, RSV, and Adenovirus antigens.

CE Certified
ISO 13485
Main image of Coronavirus (COVID-19)/Influenza A/B (Flu A/B)/Respiratory Syncytial Virus (RSV)/Adenovirus (Adeno) Antigen Combo Rapid Test

Why Choose reOpenTest Infectious Disease Kits?

Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.

Rapid Testing

Get results in just 15 minutes, enabling quick decision-making.

Comprehensive Detection

Simultaneously detects four common respiratory viruses.

Easy to Use

Simple procedure suitable for point-of-care settings.

Product Overview

The Coronavirus (COVID-19)/Influenza A/B (Flu A/B)/Respiratory Syncytial Virus (RSV)/Adenovirus (Adeno) Antigen Combo Rapid Test is an in vitro diagnostic device for the detection of SARS-CoV-2, Influenza A and B, RSV and Adenovirus antigens in nasal or nasopharyngeal swab specimens. Results are available in 15 minutes.

Technical Specifications

Detection Target SARS-CoV-2, Influenza A, Influenza B, RSV, Adenovirus nucleocapsid proteins
Sample Type Nasal swab, Nasopharyngeal swab
Methodology Immunochromatography
Detection Range Qualitative (Positive/Negative)
Reaction Time 10-15 minutes
Storage Conditions 2-30u00b0C
Shelf Life 24 months

Procedure & Interpretation

Step-by-Step Procedure

  1. Collect nasal or nasopharyngeal swab sample.
  2. Apply sample to the test device.
  3. Wait 15 minutes.
  4. Read and interpret the results.

Result Interpretation

Positive Result
Positive: Visible lines for any of the target viruses indicate a positive result for that virus.
Negative Result
Negative: Only the control line is visible, indicating a negative result.
Invalid Result
Invalid: If the control line is not visible, the test is invalid and should be repeated.

Frequently Asked Questions

Simultaneous detection allows for rapid differential diagnosis, enabling timely treatment decisions and appropriate infection control measures, especially during peak respiratory virus seasons.

Yes, this test is designed to specifically identify and differentiate between Influenza A and Influenza B viruses, providing more detailed diagnostic information.

The test should be stored at 2-30u00b0C and handled according to standard laboratory safety procedures. Avoid freezing the test kits.

Technical Documents

Download product inserts and brochures for detailed information.

No technical documents are available at this time. Please check back soon.

Partner with reOpenTest

Provide your clients and patients with reliable diagnostic solutions.
Contact us today for bulk pricing and distribution opportunities.

Become a Distributor